The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Antisense oligonucleotide pharmacokinetics and metabolism
Abstract
BACKGROUND: The use of oligonucleotides as therapeutic agents has elicited a great deal of interest. Basic understanding and evaluation of the pharmacokinetic properties of oligonucleotides is foundational to their appropriate design and application. OBJECTIVE: To review the primary pharmacokinetic properties that drive successful use and delivery of oligonucleotides. METHODS: The primary data set available in the published literature for summarizing the pharmacokinetic properties of oligonucleotides exists for single strand phosphorothioate antisense oligonucleotides and their chimeric chemical modifications (second generation). Where possible, data from other classes of compounds are contrasted with this base class. RESULTS/CONCLUSION: Although there are several different classes of oligonucleotides being developed as therapeutic agents, their pharmacokinetic properties by class are primarily a function of their backbone chemistry and the resulting chemical relationship to biological stability and plasma protein binding properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357 · cited 1×
“(2009) 5(4) approaches for RNAi have shown promising single dose pharmacology in the liver of nonhuman primates [35,36].”
BackgroundSISSAOUI, M. (2018) · Archives of Clinical Microbiology · doi:10.4172/1989-8436-c3-011 · Cited by 1,349
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150
Frank-Kamenetsky, M., Grefhorst, A., Anderson, N. N., Racie, T. S., Bramlage, B., Akinc, A., Butler, D., Charisse, K., Dorkin, R., Fan, Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805434105 · Cited by 642
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
Agrawal, S., Temsamani, J., & Tang, J. Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7595 · Cited by 561
Antisense oligonucleotide therapy for neurodegenerative disease
Smith, R. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25424 · Cited by 506
Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents
Vickers, T. A., Koo, S., Bennett, C. F., Crooke, S. T., Dean, N. M., & Baker, B. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210326200 · Cited by 461
Reich, S. J., Fosnot, J., Kuroki, A. M., Tang, W., Yang, X., Maguire, A. M., Bennett, J., & Tolentino, M. J. (2003) · PubMed · Cited by 441
Levin, A. A. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00140-2 · Cited by 438
Kastelein, J. J. P., Wedel, M. K., Baker, B. F., Su, J., Bradley, J. D., Yu, R. Z., Chuang, E., Graham, M. J., & Crooke, R. M. (2006) · Circulation · doi:10.1161/circulationaha.105.606442 · Cited by 358
RNA interference and chemically modified small interfering RNAs
Manoharan, M. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.10.007 · Cited by 346
Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats
Geary, R. S., Watanabe, T. A., Truong, L., Freier, S., Lesnik, E. A., Sioufi, N. B., Sasmor, H., Manoharan, M., & Levin, A. A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38831-7 · Cited by 288
Self-citationZhang, H., Cook, J., Nickel, J., Yu, R., Stecker, K., Myers, K., & Dean, N. M. (2000) · Nature Biotechnology · doi:10.1038/78475 · Cited by 268
Cossum, P. A., Sasmor, H., Dellinger, D., Truong, L., Cummins, L., Owens, S. R., Markham, P. M., Shea, J. P., & Crooke, S. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39459-0 · Cited by 265
Pharmacokinetics of Antisense Oligonucleotides
Agrawal, S., Temsamani, J., Galbraith, W., & Tang, J. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199528010-00002 · Cited by 261
Biodistribution of phosphodiester and phosphorothioate siRNA
Braasch, D. A., Paroo, Z., Constantinescu, A., Ren, G., Öz, O. K., Mason, R. P., & Corey, D. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.074 · Cited by 251
Yu, R. Z., Kim, T.-W., Hong, A., Watanabe, T. A., Gaus, H. J., & Geary, R. S. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012401 · Cited by 244
Self-citationPerry, C. M., & Barman Balfour, J. A. (1999) · Drugs · doi:10.2165/00003495-199957030-00010 · Cited by 243
Fomivirsen – a phosphorothioate oligonucleotide for the treatment of CMV retinitis
de Smet, M. D., Meenken, C., & van den Horn, G. J. (1999) · Ocular Immunology and Inflammation · doi:10.1076/ocii.7.3.189.4007 · Cited by 187
Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers
AMANTANA, A., & IVERSEN, P. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.07.001 · Cited by 163
Geary, R. S., Yu, R. Z., Watanabe, T., Henry, S. P., Hardee, G. E., Chappell, A., Matson, J., Sasmor, H., Cummins, L., & Levin, A. A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1419 · Cited by 162
Self-citationFomivirsen: Clinical Pharmacology and Potential Drug Interactions
Geary, R. S., Henry, S. P., & Grillone, L. R. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241040-00002 · Cited by 160
Self-citationAntisense oligodeoxynucleotide reduces brain dopamine D2 receptors: Behavioral correlates
Zhang, M., & Creese, I. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90299-z · Cited by 150
Graham, M. J., Crooke, S. T., Monteith, D., Cooper, S. R., Lemonidis, K. M., Stecker, K., Martin, M. J., & Crooke, R. M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37605-0 · Cited by 140
Miner, P. B., Wedel, M. K., Bane, B. L., & Bradley, J. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01863.x · Cited by 133
Oral Delivery of Antisense Oligonucleotides in Man
Tillman, L., Geary, R. S., & Hardee, G. E. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21084 · Cited by 127
Self-citationZhang, R., Diasio, R. B., Lu, Z., Liu, T., Jiang, Z., Galbraith, W. M., & Agrawal, S. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00010-w · Cited by 125
Yu, R. Z., Lemonidis, K. M., Graham, M. J., Matson, J. E., Crooke, R. M., Tribble, D. L., Wedel, M. K., Levin, A. A., & Geary, R. S. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.005 · Cited by 125
Self-citationSewell, K. L., Geary, R. S., Baker, B. F., Glover, J., Mant, T., Yu, R. Z., Tami, J. A., & Dorr, F. A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.036749 · Cited by 121
Self-citationPlasma Protein Binding of an Antisense Oligonucleotide Targeting Human ICAM-1 (ISIS 2302)
Watanabe, T. A., Geary, R. S., & Levin, A. A. (2006) · Oligonucleotides · doi:10.1089/oli.2006.16.169 · Cited by 120
Self-citationOn-Line HPLC Electrospray Mass Spectrometry of Phosphorothioate Oligonucleotide Metabolites
Gaus, H. J., Owens, S. R., Winniman, M., et al. (1997) · Analytical Chemistry · doi:10.1021/ac960557q · Cited by 114
Tissue Disposition of 2′‐O‐(2‐methoxy) ethyl Modified Antisense Oligonucleotides in Monkeys
Yu, R. Z., Geary, R. S., Monteith, D., Matson, J. E., Truong, L., Fitchett, J. R., & Levin, A. A. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10473 · Cited by 114
Self-citationCossum, P. A., Truong, L., Owens, S. R., Markham, P. M., Shea, J. P., & Crooke, S. T. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38714-8 · Cited by 110
Yu, R. Z., Geary, R. S., Flaim, J., Riley, G. C., Tribble, D. L., vanVliet, A. A., & Wedel, M. K. (2008) · Clinical Pharmacokinetics · doi:10.2165/0003088-200948010-00003 · Cited by 103
Self-citationPhillips, J. A., Craig, S. J., Bayley, D., Christian, R. A., Geary, R., & Nicklin, P. L. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00190-1 · Cited by 103
Self-citationGeary, R. S., Leeds, J. M., Fitchett, J. R., et al. (1997) · PubMed · Cited by 98
Self-citationIn vivo stability, disposition and metabolism of a “hybrid” oligonucleotide phosphorothioate in rats
Zhang, R., Lu, Z., Zhao, H., Zhang, X., Diasio, R. B., Habuš, I., Jiang, Z., Iyer, R. P., Dong, Y. J., & Agrawal, S. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00159-w · Cited by 97
Anti-Inflammatory Activity of Inhaled IL-4 Receptor-α Antisense Oligonucleotide in Mice
Karras, J. G., Crosby, J. R., Guha, M., Tung, D., Miller, D. A., Gaarde, W. A., Geary, R. S., Monia, B. P., & Gregory, S. A. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0456oc · Cited by 95
Self-citationLorenz, P. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.2.582 · Cited by 94
Geary, R. S., Leeds, J. M., Henry, S. P., Monteith, D., & Levin, A. A. (1997) · PubMed · Cited by 90
Self-citationAdjei, A. A., Dy, G. K., Erlichman, C., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Atherton, P. J., et al. (2003) · PubMed · Cited by 88
Self-citationArora, V., Knapp, D. C., Reddy, M. T., Weller, D. D., & Iversen, P. L. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10088 · Cited by 82
Arora, V., Devi, G. R., & Iversen, P. L. (2004) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201043376706 · Cited by 77
Yu, R. Z., Zhang, H., Geary, R. S., Graham, M., Masarjian, L., Lemonidis, K. M., Crooke, R. M., Dean, N. M., & Levin, A. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38750-6 · Cited by 72
Self-citationMetabolism of Antisense Oligonucleotides in Rat Liver Homogenates
Crooke, R. M., Graham, M. J., Martin, M. J., Lemonidis, K. M., Wyrzykiewiecz, T., & Cummins, L. L. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35270-x · Cited by 69
Templin, M. V., Levin, A. A., Graham, M. J., Åberg, P. M., AXELSSON, B. I., Butler, M., Geary, R. S., & Bennett, C. F. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.359 · Cited by 60
Self-citationMani, S., Rudin, C. M., Kunkel, K., Holmlund, J., Geary, R. S., Kindler, H. L., Dorr, F. A., & Ratain, M. J. (2002) · PubMed · Cited by 58
Self-citationMiner, P. B., Geary, R. S., Matson, J. E., Chuang, E., Xia, S., Baker, B. F., & Wedel, M. K. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02909.x · Cited by 54
Self-citationAbsorption of Antisense Oligonucleotides in Rat Intestine: Effect of Chemistry and Length
Khatsenko, O. G., MORGAN, R., Truong, L., York-DeFalco, C., Sasmor, H. M., Conklin, B., & Geary, R. S. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.35 · Cited by 51
Self-citationGeary, R. S., Bradley, J. D., Watanabe, T. A., et al. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645080-00003 · Cited by 50
Self-citationGeary, R. S., Khatsenko, O. G., Bunker, K., Crooke, R. M., Moore, M., Burckin, T., Truong, L., Sasmor, H. M., & Levin, A. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38832-9 · Cited by 49
Self-citationGraham, M. J., Crooke, S. T., Lemonidis, K. M., Gaus, H. J., Templin, M. V., & Crooke, R. M. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00669-4 · Cited by 45
Butler, M., Hayes, C. S., Chappell, A. E., Murray, S., Yaksh, T. L., & Hua, X. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.11.038 · Cited by 44
Senn, C., Hangartner, C., Moes, S., Guerini, D., & Hofbauer, K. G. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.08.021 · Cited by 44
Crosby, J. R., Guha, M., Tung, D., Miller, D. A., Bender, B., Condon, T. P., York-DeFalco, C., Geary, R. S., Monia, B. P., Karras, J. G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.119214 · Cited by 43
Self-citationBiodistribution of 68 Ga-Labeled LNA–DNA Mixmer Antisense Oligonucleotides for Rat Chromogranin-A
Lendvai, G., Velikyan, I., Estrada, S., Eriksson, B. K., Långström, B., & Bergström, M. (2008) · Oligonucleotides · doi:10.1089/oli.2007.0104 · Cited by 24
Cellular Delivery of Peptide Nucleic Acid by Cell-Penetrating Peptides
Kilk, K., & Langel, Ü. (2005) · Humana Press eBooks · doi:10.1385/1-59259-877-3:131 · Cited by 21
Thielecke, F., & Noack, R. (1997) · Journal of Mass Spectrometry · doi:10.1002/(sici)1096-9888(199703)32:3<305::aid-jms482>3.0.co;2-r · Cited by 20
Pharmacokinetic Properties of Phosphorothioate Oligonucleotides
Leeds, J. M., Geary, R. S., Henry, S. P., et al. (1997) · Nucleosides and Nucleotides · doi:10.1080/07328319708006256 · Cited by 18
Self-citationPharmacokinetic Properties of Phosphorothioate Oligonucleotides in Humans
Leeds, J. M., & Geary, R. S. (1998) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-58785-6_6 · Cited by 12
Self-citationYu, R. Z., Geary, R. S., Siwkowski, A. M., & Levin, A. A. (2007) · CRC Press eBooks · doi:10.1201/9780849387951.ch11 · Cited by 7
Self-citationManoharan, M., & Rajeev, K. G. (2007) · CRC Press eBooks · doi:10.1201/9780849387951.ptb · Cited by 5
Cited by
Bennett, C. F., & Swayze, E. E. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105654 · Cited by 1,374
Therapeutic targeting of microRNAs: current status and future challenges
Li, Z., & Rana, T. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4359 · Cited by 1,033
The delivery of therapeutic oligonucleotides
Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 854
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
Geary, R. S., Norris, D., Yu, R., & Bennett, C. F. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.008 · Cited by 845
Self-citationCrooke, S. T., Witztum, J. L., Bennett, C. F., & Baker, B. F. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.004 · Cited by 841
Metadata
- Authors
- Geary, R. S.
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2009-04
- Volume
- 5
- Issue
- 4
- Pages
- 381-391
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W2044204671
- Cited by
- 300
- References
- 62
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.